Share
array:24 [ "pii" => "S2530312024000316" "issn" => "25303120" "doi" => "10.1016/j.rcpeng.2022.02.006" "estado" => "S300" "fechaPublicacion" => "2024-04-01" "aid" => "528" "copyright" => "Asociación Colombiana de Psiquiatría" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Colomb Psiquiatr. 2024;53:206-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S0034745022000245" "issn" => "00347450" "doi" => "10.1016/j.rcp.2022.02.003" "estado" => "S300" "fechaPublicacion" => "2024-04-01" "aid" => "528" "copyright" => "Asociación Colombiana de Psiquiatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Colomb Psiquiatr. 2024;53:206-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Reporte de caso</span>" "titulo" => "Case Report of Retarded Catatonia: Always Consider Catatonia as a Differential Diagnosis of Altered Mental Status" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "206" "paginaFinal" => "209" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Informe de un caso de catatonia retardada: Considerar siempre la catatonia como diagnóstico diferencial de la alteración del estado mental" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Irma Munoz Verdugo, Jose Lopez, Sandra Cordova" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Irma" "apellidos" => "Munoz Verdugo" ] 1 => array:2 [ "nombre" => "Jose" "apellidos" => "Lopez" ] 2 => array:2 [ "nombre" => "Sandra" "apellidos" => "Cordova" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2530312024000316" "doi" => "10.1016/j.rcpeng.2022.02.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530312024000316?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0034745022000245?idApp=UINPBA00004N" "url" => "/00347450/0000005300000002/v1_202405231606/S0034745022000245/v1_202405231606/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2530312024000298" "issn" => "25303120" "doi" => "10.1016/j.rcpeng.2022.03.001" "estado" => "S300" "fechaPublicacion" => "2024-04-01" "aid" => "531" "copyright" => "Asociación Colombiana de Psiquiatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Colomb Psiquiatr. 2024;53:210-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Successful treatment for serious depression with suicidal risk in a heart transplant patient" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "210" "paginaFinal" => "216" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento Exitoso para la Depresión Grave con Riesgo Suicida en un Paciente Trasplantado de Corazón" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 4175 "Ancho" => 2797 "Tamanyo" => 1064241 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Timeline.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María del Mar Arango-Posada, Ana Isabel Prada-Escobar, Carolina Marín-Hernández, Veronica Monsalve-Franco, Diana Restrepo-Bernal" "autores" => array:5 [ 0 => array:2 [ "nombre" => "María del Mar" "apellidos" => "Arango-Posada" ] 1 => array:2 [ "nombre" => "Ana Isabel" "apellidos" => "Prada-Escobar" ] 2 => array:2 [ "nombre" => "Carolina" "apellidos" => "Marín-Hernández" ] 3 => array:2 [ "nombre" => "Veronica" "apellidos" => "Monsalve-Franco" ] 4 => array:2 [ "nombre" => "Diana" "apellidos" => "Restrepo-Bernal" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0034745022000269" "doi" => "10.1016/j.rcp.2022.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0034745022000269?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530312024000298?idApp=UINPBA00004N" "url" => "/25303120/0000005300000002/v1_202408270644/S2530312024000298/v1_202408270644/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2530312024000250" "issn" => "25303120" "doi" => "10.1016/j.rcpeng.2022.01.004" "estado" => "S300" "fechaPublicacion" => "2024-04-01" "aid" => "525" "copyright" => "Asociación Colombiana de Psiquiatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Rev Colomb Psiquiatr. 2024;53:192-205" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "Adherence to psychopharmacological treatment in patients with severe and persistent mental disorders: A systematic review" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "192" "paginaFinal" => "205" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Adherencia al Tratamiento Psicofarmacológico de los Pacientes con Trastornos Mentales Graves y Persistentes: Revisión Sistemática" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2893 "Ancho" => 2500 "Tamanyo" => 408961 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">PRISMA article selection and exclusion diagram.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María José Alvear Velásquez, Iván Patricio Sandoval Carrión" "autores" => array:2 [ 0 => array:2 [ "nombre" => "María José" "apellidos" => "Alvear Velásquez" ] 1 => array:2 [ "nombre" => "Iván Patricio" "apellidos" => "Sandoval Carrión" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S003474502200018X" "doi" => "10.1016/j.rcp.2022.01.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S003474502200018X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530312024000250?idApp=UINPBA00004N" "url" => "/25303120/0000005300000002/v1_202408270644/S2530312024000250/v1_202408270644/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Reporte de caso</span>" "titulo" => "Case Report of Retarded Catatonia: Always Consider Catatonia as a Differential Diagnosis of Altered Mental Status" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "206" "paginaFinal" => "209" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Irma Munoz Verdugo, Jose Lopez, Sandra Cordova" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Irma" "apellidos" => "Munoz Verdugo" "email" => array:1 [ 0 => "irmamunozmd@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Jose" "apellidos" => "Lopez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Sandra" "apellidos" => "Cordova" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Department of Internal Medicine, Facultad de Ciencias Médicas, Universidad de Cuenca, Cuenca, Ecuador" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Internal Medicine, Doctors Hospital at Renaissance DHR Hospital, McAllen, United States of America" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Internal Medicine, Universidad Central del Ecuador, Quito, Ecuador" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Informe de un caso de catatonia retardada: Considerar siempre la catatonia como diagnóstico diferencial de la alteración del estado mental" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Catatonia is a medical condition associated with mood-affective disorders, schizophrenia, neurological and medical conditions; it is characterized by an inability to move, mutism, rigidity, and refusal to eat, among others. To date, there are two types: retarded and excited.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">1,2</span></a> Some prospective studies suggest that catatonia can be observed in 10% of patients at psychiatric units and in up to 30% of patients admitted to medical wards.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Imbalances in the excitatory-to-inhibitory ratio (EIR) at the spinal and brainstem level may play a role in the etiology.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">4</span></a> In addition, research reported that the GABA pathway has a part in the suppression of the immune response.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">5</span></a> This is why some patients with catatonia respond to agonists of GABA-A receptors.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Catatonia can be diagnosed based on clinical suspicion, at least four catatonic symptoms must be present for a diagnosis. In addition, a trial of lorazepam is required to support the diagnosis.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">6</span></a> Catatonia can be challenging when doctors are trying to obtain a medical history and physical examination because patients manifest with mutism, and so this lack of information can difficult a correct diagnosis, assessment, and plan.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">2,7</span></a> Is not a rare medical condition encountered at the emergency department and in the acute care setting, but due to the diverse presentation of catatonia, it can be misdiagnosed.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">6,8</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Patients with catatonia and comorbid mood disorders can resolve their condition completely with benzodiazepine treatment and electroconvulsive therapy.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">9</span></a> Moreover, some cases will need a specialized level of care, nasogastric tube placement, intravenous fluids, and anticoagulation to decrease morbidity and mortality.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">10</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Case presentation</span><p id="par0025" class="elsevierStylePara elsevierViewall">The patient is a 59-year-old woman with a background of longstanding cirrhosis, bipolar disorder, and major depressive disorder with psychotic features, stable on alprazolam, fluoxetine, and lurasidone. It allowed her to live an independent life. The patient was brought to the behavioral facility complaining about increased agitation, auditory and visual hallucinations (she was seeing bugs on her arms, hair, and on the wall as well as seeing a red light that was coming out from the television), uncooperative, no insight into her condition and judgment severely impaired. In the facility, the patient was started on a tapering dose of clorazepate (Tranxene 7.5<span class="elsevierStyleHsp" style=""></span>mg) detoxification schedule with thiamine and folic acid. As per the mother and medical staff, the patient developed an episode of tonic-clonic seizure, which prompted them to transfer her to the ER. Upon admission, her vital signs were temperature of 101.4, tachycardic to 116, and slightly hypertensive. On examination, the patient was posturing, staring stuporous, nonverbal, nonresponsive, flat affect, stiff, increased tone of four extremities, and waxy resistance to passive movement. She had, another episode of seizure in the ER, and an initial diagnosis of possible sepsis, benzodiazepine withdrawal, or hepatic encephalopathy was made. She was admitted to the Internal Medicine ward, and extensive neurologic, infectious, and toxicologic work-up (amphetamine, barbiturates, opioids negative, and benzodiazepines positive) was done including lumbar and imaging such as CT head without contrast, CT angiography of the neck, EEG, echocardiogram, and chest x-ray which were normal. Ammonia level was elevated just on admission. The patient failed swallow evaluation and was placed on NPO, metoprolol IV, and lorazepam 1<span class="elsevierStyleHsp" style=""></span>mg IV BID, and levetiracetam 500<span class="elsevierStyleHsp" style=""></span>mg BID. Throughout hospitalization, her mental status decline progressively despite the use of lactulose for metabolic encephalopathy and with only short episodes of lucidity shortly after being administered IV benzodiazepines, but she remained with mutism, not following commands, looking in space, mumbling. Despite her presentation, the impression was that she was suffering from acute retarded catatonic syndrome secondary to her bipolar affective disorder. Psychiatry and Internal Medicine agreed to start a trial of IV benzodiazepines at a therapeutic dose for catatonia (lorazepam 3<span class="elsevierStyleHsp" style=""></span>mg IV every 8 h). After the administration of lorazepam patient improve substantially and progressively, initially somewhat catatonic, but later able to verbalize again with better eye tracking and able to ask for water and her mood was euthymic. She was able to follow simple commands without difficulty, the patient presented a favorable evolution without any complications A final recommendation to the patient was to be transferred to a hospital that had electroconvulsive therapy for definitive treatment.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Discussion</span><p id="par0030" class="elsevierStylePara elsevierViewall">Diagnosis of acute catatonia is a challenge for both hospitalists and psychiatrists because it is difficult to obtain a complete medical history from a mute patient. In this context, it is primordial to be sure that some medical conditions such as non-convulsive status epilepticus, stroke, abulia, akinetic mutism, delirium, and dementia are not present at diagnosis.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">2</span></a> Moreover, neurological emergencies (neuroleptic malignant syndrome NMS), need to be ruled out before considering acute catatonia as those conditions need a prompt diagnosis, treatment, and admission to the medical intensive care unit (MICU).<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">11</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">According to Karl Kahlbaum, catatonia is diagnosed when a patient has at least 4 of 11 signs and symptoms.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">2</span></a> The most common signs and symptoms of catatonia are immobility and mutism; those are present in about 90% of cases (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">2</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">Treatment of catatonia should be started as soon as catatonia is suspected and is critical for a good patient's progress and recovery. In all cases of catatonia, the underlying disorder (e.g. undiagnosed bipolar disorder) has to be addressed. It is a priority to discontinue any potential hazardous drugs that cause catatonia such as dopamine antagonists, anticonvulsants, and antipsychotics, etc.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">6</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Current recommendations are based on the general condition of the patient. For instance, non-life-threatening catatonia is treated by the administration of benzodiazepines. If the patient responds within one week, there is no need to continue the benzodiazepine medication at discharge. However, if the patient has a slow response (clinical response after the first week) there is a need to initiate electroconvulsive therapy.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">12</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">Among the most common benzodiazepines (GABA agonist drugs) used in catatonia are lorazepam and clonazepam.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">11,13</span></a> Initially, it is recommended to start with a dose of 2<span class="elsevierStyleHsp" style=""></span>mg of lorazepam intravenously. If there is a good response, it is advised to schedule the drug up to three times a day.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">6</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Benzodiazepines’ response has been demonstrated in many studies, a clinical response is achieved within 3<span class="elsevierStyleHsp" style=""></span>hours after the administration of lorazepam. The oral route is preferred, however, when that is not feasible an intramuscular or intravenous route should be used. Most patients recovered their baseline clinical state with a lorazepam dose between 1 to 3<span class="elsevierStyleHsp" style=""></span>mg.<a class="elsevierStyleCrossRefs" href="#bib0175"><span class="elsevierStyleSup">14,15</span></a> As the patient's mental state improves focus should be placed on the underlying medical condition.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">6</span></a> In our case, no organic cause was identified and we focused on treating the acute catatonic state.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Duration of therapy varies according to clinical response; some patients might need a single dose and other patients might require multiple doses or even a continuous infusion. Response to therapy can be evaluated by the Bush-Francis catatonia scale.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">15</span></a> After a therapeutic dose of lorazepam is achieved, tapering of the drug should be done slowly to prevent a new episode of catatonia.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">6</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">Research about other therapeutic options than lorazepam is controversial and non-conclusive. Current treatments studied for catatonia are clonazepam, antipsychotics (olanzapine), dantrolene, amantadine, and zolpidem which have been reported good results.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">16–18</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">Antipsychotics have been evaluated in patients with catatonia and an underlying psychotic condition. Among the antipsychotics studied, there is clozapine, which is a low-affinity dopamine receptor agonist. Clozapine showed a beneficial effect in psychotic patients.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">15</span></a> The use of second-generation (atypical) antipsychotics was preferred over traditional first-generation because of the lower risk of developing neuroleptic malignant syndrome.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">13</span></a> Even though antipsychotics were used in some cases, the current recommendation is against the use of all dopamine blocking drugs (antiemetic agents, first and second-generation antipsychotics) because all antipsychotics might worsen catatonia. If the underlying disorder is a psychotic condition that needs antipsychotic medication, the antipsychotic drug could be resumed with extreme caution only once the patient is stable, eating and drinking adequately, and without any signs of catatonia.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">12</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Clonazepam was used in some studies only after achieving an initial response with lorazepam. Clonazepam was preferred over lorazepam in patients who needed longer hospitalization. The pharmacologic properties of clonazepam, a longer half-life, were well suited for patients suffering from catatonia and COVID-19 pneumonia.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">19</span></a></p><p id="par0080" class="elsevierStylePara elsevierViewall">Olanzapine and lorazepam, as a combination therapy, showed a good response in patients with catatonia secondary to anti-NMDA receptor encephalitis. Olanzapine alone was not as effective as in combination with lorazepam to improve agitation.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">20</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Zolpidem has been studied in cases of resistant catatonia in adolescents. The drug has a similar mechanism of action to lorazepam, a positive allosteric effect on GABA-A receptors. However, zolpidem binds to a specific subunit (alpha1) rather than a non-specific site on the receptor. Zolpidem might be a non-benzodiazepine alternative in cases of resistant catatonia, although more research is needed.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">21</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">According to Freitas de Lucena et al.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">15</span></a>, 500<span class="elsevierStyleHsp" style=""></span>mg of amantadine intravenously can be beneficial in the treatment of catatonia as many motor scores showed a complete improvement after a couple of hours. However, amantadine is not routinely used because has dopamine agonist properties and can exacerbate psychotic symptoms.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">12</span></a></p><p id="par0095" class="elsevierStylePara elsevierViewall">Electroconvulsive therapy (ECT) is a well-studied treatment for catatonia. ECT in combination with benzodiazepines is recommended as initial treatment in patients with life-threatening (malignant) catatonia. In addition, ECT is recommended in patients who did not respond within the first week of lorazepam administration.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">12</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">In some studies, the frequency of bilateral ECT was three-time per week. In addition, unilateral ECT was preferred over bilateral to prevent cognitive impairments such as headaches and memory loss. These adverse effects might be related to the frequency of electroconvulsive therapy.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">15</span></a> In our patient, lorazepam was the initial treatment and ECT was considered as a definitive treatment. Multiple studies showed a recovery rate of up to 80% with lorazepam alone, ECT alone, and ECT after lorazepam.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">12</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">There are common complications in catatonia such as refusing to eat, dehydration, pneumonia, pressure ulcers, deep venous thrombosis, and pulmonary embolus.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">2,6</span></a> In the last decade, catatonia has had an excellent response (80%) and prognosis to benzodiazepines (lorazepam). The patients who do not respond to lorazepam usually have a bad prognosis later.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">6,15</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Conclusions</span><p id="par0110" class="elsevierStylePara elsevierViewall">Catatonia is underdiagnosed due to the lack of awareness of the condition among both medical doctors and psychiatrists. We always have to consider acute catatonia syndrome among our differential diagnoses for altered mental status.</p><p id="par0115" class="elsevierStylePara elsevierViewall">As catatonia is a highly treatable condition, there must be a high suspicion to diagnose and treat this disease. Failure to do so increases the morbidity and mortality outcome among patients.</p><p id="par0120" class="elsevierStylePara elsevierViewall">More research is required to do a catatonia protocol, thereby it is important to have further data on patients with catatonia.</p><p id="par0125" class="elsevierStylePara elsevierViewall">ECT has proved to be efficacy in refractory catatonia, as well as in the incomplete response to benzodiazepines.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Conflicto de intereses</span><p id="par0130" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres2229640" "titulo" => "Abstract" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Case report" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1867171" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres2229641" "titulo" => "Resumen" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Caso clínico" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1867170" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Case presentation" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Conclusions" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Conflicto de intereses" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2021-09-24" "fechaAceptado" => "2022-02-02" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1867171" "palabras" => array:3 [ 0 => "Catatonia" 1 => "Benzodiazepines" 2 => "Electroconvulsive therapy" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1867170" "palabras" => array:3 [ 0 => "Catatonía" 1 => "Benzodiacepinas" 2 => "Terapia electroconvulsiva" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Catatonia is a rare neuropsychiatric condition; it is estimated that around 10% of patients with mood disorders present signs and symptoms of catatonia. A catatonic syndrome is characterised by mutism, negativism, rigidity, and stupor.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Case report</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We report the case of a 59-year-old patient with a medical history of bipolar disorder who was admitted to the internal medicine service due to a seizure episode. During hospitalisation, the patient presented significant worsening of her clinical condition, showing marked symptoms of stupor and catatonia. Once the neurological and metabolic etiologies of altered mental status had been ruled out, pharmacological treatment with high doses of lorazepam was started. The patient had a complete clinical remission, and her evolution was favourable without any complications. Electroconvulsive therapy was recommended as a definitive treatment.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Conclusions</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The diagnosis of catatonia is a challenge for both hospitalists and psychiatrists due to the clinical presentation of catatonia. In reporting this clinical case, we want to emphasise the importance of taking into account the catatonic syndrome in our differential diagnoses in patients with altered mental status.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Case report" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introducción</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">La catatonía es una condición neuropsiquiátrica poco frecuente, se estima que cerca del 10% de los pacientes con trastornos afectivos presentan signos y síntomas de catatonía. El síndrome se caracteriza clínicamente por mutismo, negativismo, rigidez y estupor.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Caso clínico</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Se describe el caso clínico de una paciente de 59 años con antecedentes de trastorno bipolar, ingresada por el servicio de medicina interna por un episodio de crisis convulsiva. Durante la hospitalización, la paciente presentó un importante deterioro clínico, marcado estupor y síntomas de catatonía. Una vez descartadas etiologías neurológicas y metabólicas de la alteración del estado de conciencia, se inició el tratamiento farmacológico con altas dosis de lorazepam. El cuadro clínico de la paciente evolucionó favorablemente con una remisión clínica completa.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conclusiones</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El diagnóstico de catatonía constituye un reto tanto para médicos internistas como psiquiatras por su presentación clínica. Con el reporte de este caso clínico se desea enfatizar la importancia de considerar al síndrome catatónico en nuestros diagnósticos diferenciales en pacientes con alteración del estado de conciencia.</p></span>" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Caso clínico" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusiones" ] ] ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Sign \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">% Of patients \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Immobility \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">97 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mutism \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">97 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Withdrawal and refusal to eat \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">91 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Staring \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">87 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Negativism \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">67 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Posturing \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">58 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rigidity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">54 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Waxy flexibility/catalepsy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">27 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stereotypy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Echolalia or echopraxia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Verbigeration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3635046.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Signs and symptoms of Acute Catatonia by Karl Kahlbaum et al<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">2</span></a>.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:21 [ 0 => array:3 [ "identificador" => "bib0110" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute catatonia on medical wards: a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Doran" 1 => "J.D. Sheehan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Med Case Reports." "fecha" => "2018" "volumen" => "12" "paginaInicial" => "206" "itemHostRev" => array:3 [ "pii" => "S2213219818301181" "estado" => "S300" "issn" => "22132198" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0115" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catatonia: Our current understanding of its diagnosis, treatment, and pathophysiology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.A. Rasmussen" 1 => "M.F. Mazurek" 2 => "P.I. Rosebush" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5498/wjp.v6.i4.391" "Revista" => array:7 [ "tituloSerie" => "World J Psychiatry." "fecha" => "2016" "volumen" => "6" "paginaInicial" => "391" "paginaFinal" => "398" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28078203" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0091674903008492" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0120" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 Catatonia—Would we even know?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.J. Cooper" 1 => "D.A. Ross" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Biol Psychiatry." "fecha" => "2020" "volumen" => "1" "paginaInicial" => "19" "paginaFinal" => "21" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0125" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The excitatory: inhibitory ratio model (EIR model): an integrative explanation of acute autonomic overactivity syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "I.J. Baguley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.mehy.2007.04.037" "Revista" => array:6 [ "tituloSerie" => "Med Hypotheses." "fecha" => "2008" "volumen" => "70" "paginaInicial" => "26" "paginaFinal" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17583440" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0130" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catatonia and the immune system: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J. Rogers" 1 => "T. Pollak" 2 => "G. Blackman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet." "fecha" => "2019" "volumen" => "6" "paginaInicial" => "620" "paginaFinal" => "630" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0135" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catatonia. [Updated 2021 May 21]. In: StatPearls [Internet" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.P. Burrow" 1 => "B.C. Spurling" 2 => "Marwaha R:" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Treasure Island (FL): StatPearls Publishing;" "fecha" => "2021" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/37116037" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0140" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Case of catatonia misdiagnosed with coma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Fu" 1 => "C. Yanfang" 2 => "C. Shaohua" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gen Psychiatr." "fecha" => "2020" "volumen" => "22" "paginaInicial" => "100059" "paginaFinal" => "100110" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0145" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Benzodiazepine withdrawal catatonia, delirium, and seizures in a patient with schizoaffective disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E.C. Mader Jr." 1 => "S.H. Rathore" 2 => "J.D. England" 3 => "L.A. Branch" 4 => "B.J. Copeland" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "J Investig Med High Impact Case Rep." "fecha" => "2020" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0150" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electroconvulsive therapy for patients with catatonia: current perspectives" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.R. Lloyd" 1 => "E.R. Silverman" 2 => "J.L. Kugler" 3 => "J.J. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Neuropsychiatr Dis Treat." "fecha" => "2020" "volumen" => "25" "paginaInicial" => "2191" "paginaFinal" => "2208" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0155" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A clinical review of the treatment of catatonia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P. Sienaert" 1 => "D. Dhossche" 2 => "D. Vancampfort" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Front Psychiatry." "fecha" => "2014" "volumen" => "5" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0160" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catatonia in psychotic patients: clinical features and treatment response" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.L. England" 1 => "D. Öngür" 2 => "G.T. Konopaske" 3 => "R. Karmacharya" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/jnp.23.2.jnp223" "Revista" => array:6 [ "tituloSerie" => "J Neuropsychiatry Clin Neurosci." "fecha" => "2011" "volumen" => "23" "paginaInicial" => "223" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21677256" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0165" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Coffey MJ. Catatonia: Treatment and prognosis. In: UpToDate. Roy PP, Marder S (ed): UpToDate, 2021." ] ] ] 12 => array:3 [ "identificador" => "bib0170" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: Psychometric validity and response to antipsychotic medication" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "V. Peralta" 1 => "M.S. Campos" 2 => "E.G. de Jalon" 3 => "M.J. Cuesta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.schres.2009.12.023" "Revista" => array:6 [ "tituloSerie" => "Schizophr Res." "fecha" => "2010" "volumen" => "118" "paginaInicial" => "168" "paginaFinal" => "175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20071147" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0175" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Catatonia and its treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.I. Rosebush" 1 => "M.F. Mazurek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/schbul/sbp141" "Revista" => array:6 [ "tituloSerie" => "Schizophr Bull." "fecha" => "2010" "volumen" => "36" "paginaInicial" => "239" "paginaFinal" => "242" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19969591" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0180" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of catatonia treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.C. Pelzer" 1 => "F.M. van der Heijden" 2 => "E. den Boer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Neuropsychiatr Dis Treat." "fecha" => "2018" "volumen" => "17" "paginaInicial" => "317" "paginaFinal" => "326" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0185" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid relief of catatonia in mood disorder by lorazepam and diazepam" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y.-C. Huang" 1 => "C.-C. Lin" 2 => "Y.-Y. Hung" 3 => "T.-L. Huang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/2319-4170.107162" "Revista" => array:5 [ "tituloSerie" => "Biomed J." "fecha" => "2013" "volumen" => "36" "paginaInicial" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23515153" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0190" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Gupta" 1 => "A. Dhir" 2 => "A. Kumar" 3 => "S.K. Kulkarni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pbb.2009.07.018" "Revista" => array:6 [ "tituloSerie" => "Pharmacol Biochem Behav." "fecha" => "2009" "volumen" => "94" "paginaInicial" => "219" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19666045" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0195" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of catatonia with olanzapine: A case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.-H. Chang" 1 => "Y.-L. Hsiao" 2 => "C.-Y. Hsu" 3 => "S.-T. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pnpbp.2009.08.018" "Revista" => array:7 [ "tituloSerie" => "Prog Neuropsychopharmacol Biol Psychiatry." "fecha" => "2009" "volumen" => "33" "paginaInicial" => "1559" "paginaFinal" => "1560" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19735689" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0091674917318778" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0200" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postinfectious COVID-19 catatonia: a report of two cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Torrico" 1 => "T. Kiong" 2 => "C. D’Assumpcao" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Front Psychiatry." "fecha" => "2021" "volumen" => "26" "paginaInicial" => "696347" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0205" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Olanzapine and lorazepam used in the symptomatic management of excited catatonia secondary to anti-N-methyl-D-aspartate receptor encephalitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N. Neerukonda" 1 => "M. Bliss" 2 => "A. Jafroodifar" 3 => "L. Leontieva" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Cureus." "fecha" => "2020" "volumen" => "18" "paginaInicial" => "12" "itemHostRev" => array:3 [ "pii" => "S009167491832774X" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0210" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Zolpidem in treatment resistant adolescent catatonia: a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Kumar" 1 => "D. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Scand J Child Adolesc Psychiatr Psychol." "fecha" => "2020" "volumen" => "15" "paginaInicial" => "135" "paginaFinal" => "138" "itemHostRev" => array:3 [ "pii" => "S0091674921009374" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25303120/0000005300000002/v1_202408270644/S2530312024000316/v1_202408270644/en/main.assets" "Apartado" => array:4 [ "identificador" => "66620" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case report" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25303120/0000005300000002/v1_202408270644/S2530312024000316/v1_202408270644/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530312024000316?idApp=UINPBA00004N" ]
